Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
DKSH Holdings
Acquired Company
Kyowa Kirin International and NewBridge Pharmaceuticals
Malaysia
Mount Lebanon Governorateprofessional training & coachingBiotechnologyHealth CarePharmaceuticalDescription
DKSH has signed an agreement to acquire NewBridge Pharmaceuticals for USD 390 million. This acquisition will expand DKSH Healthcare into the Middle East and enhance its capabilities in commercial outsourcing. The transaction will close by the end of Q1 2027, subject to regulatory approvals. DKSH expresses confidence in the strategic fit and growth potential of the NewBridge team.
Fundz sees it the moment DKSH Holdings makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Kyowa Kirin International and NewBridge Pharmaceuticals?
Kyowa Kirin International and NewBridge Pharmaceuticals was acquired by DKSH Holdings, based in Malaysia. The deal was reported on October 19, 2026. DKSH Holdings is a global company with a focus on providing market expansion services and business solutions in Asia. DKSH Holdings is privately held and operates in professional training & coaching.
When did DKSH Holdings acquire Kyowa Kirin International and NewBridge Pharmaceuticals?
DKSH Holdings's acquisition of Kyowa Kirin International and NewBridge Pharmaceuticals was reported on October 19, 2026. DKSH has signed an agreement to acquire NewBridge Pharmaceuticals for USD 390 million. This acquisition will expand DKSH Healthcare into the Middle East and enhance its capabilities in commercial outsourcing. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Kyowa Kirin International and NewBridge Pharmaceuticals do?
Kyowa Kirin International and NewBridge Pharmaceuticals have entered into an agreement to improve access to medicines for rare disease patients across the Middle East and North Africa. It is privately held, operating in Biotechnology, and is based in Mount Lebanon Governorate.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.